Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
McKesson
Merck
Harvard Business School
Dow

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC. (D.N.J. 2014)

See Plans and Pricing

« Back to Dashboard

HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC. (D.N.J. 2014)

Docket   Start Trial Date Filed 2014-12-23
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Noel Lawrence Hillman
Jury Demand Defendant Referred To Ann Marie Donio
Parties ACTAVIS LABORATORIES, UT, INC.; ACTAVIS PLC; ACTAVIS, INC.; ALLERGAN PLC; HORIZON PHARMA IRELAND LIMITED; HORIZON PHARMA USA, INC.; HZNP LIMITED
Patents 8,217,078; 8,252,838; 8,546,450; 8,563,613; 8,618,164; 8,741,956; 8,871,809; 9,066,913; 9,101,591; 9,132,110; 9,168,304; 9,168,305
Attorneys CHRISTINE INTROMASSO GANNON; CHRISTOPHER J. BORCHERT; JOHN EDMUND FLAHERTY; LIZA M. WALSH; RAVIN R. PATEL
Link to Docket External link to docket
Small Molecule Drugs cited in HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2016-05-06 160 SUMMARY JUDGMENT OF NON-INFRINGEMENT OF U.S. PATENT NO. 8,741,956 (WALSH, LIZA) (Entered: 05/06/2016) …23 December 2014 1:14-cv-07992 830 Patent Defendant District Court, D. External link to document
2016-05-06 162 SUMMARY JUDGMENT OF NON-INFRINGEMENT OF U.S. PATENT NO. 8,741,956 (WALSH, LIZA) (Entered: 05/06/2016) …23 December 2014 1:14-cv-07992 830 Patent Defendant District Court, D. External link to document
2016-05-06 164 Cross MOTION for Summary Judgment OF U.S. PATENT NO. 8,741,956 by ACTAVIS LABORATORIES, UT, INC.. (Attachments…23 December 2014 1:14-cv-07992 830 Patent Defendant District Court, D. External link to document
2016-05-18 173 Cross MOTION for Summary Judgment OF U.S. PATENT NO. 8,741,956, 153 MOTION to Dismiss ACTAVIS LABORATORIES…23 December 2014 1:14-cv-07992 830 Patent Defendant District Court, D. External link to document
2016-08-17 188 591 patent”), 8,546,450 (“the ’450 patent”), 8,217,078 (“the ’078 patent”), 8,618,164 (“the ’164…U.S. Patent Nos. 8,546,450; 8,217,078; 8,618,164; and 9,132,110 - are part of the “’450 Patent Family… parties. These patents are: U.S. Patent Nos. 8,252,838 (“the ’838 patent”), 8,563,613 (“the…the ’613 patent”), 8,871,809 (“the ’809 patent”), 9,066,913 (“the ’913 patent”), 9,101,591 (“the …164 patent”) and 9,132,110 (“the ’110 patent”). The patents may be segregated into groups in External link to document
2017-01-06 234 . Patent Nos. 8,546,450; 8,217,078; 8,618,164; and 9,132,110 - are part of the “’450 Patent Family” and… There are nine patents asserted in this matter. Of these, five patents - U.S. Patent Nos. 8,252,838;…the “’838 Patent Family” and all agreed to have the same specification. The other four patents - U.S. …`838 Patent Family as a whole, and has only raised the request that each claim of every patent should…Chicago, Illinois 60611 Dennis A. Bennett GLOBAL PATENT GROUP, LLC 1005 North Warson Road, Suite 404 External link to document
2017-03-03 270 defenses to induced infringement of U.S. Patents 8,217,078, 8,546,450, and 9,132,110 (Attachments: # …23 December 2014 1:14-cv-07992 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
AstraZeneca
Dow
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.